Rock Springs Capital Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-57,373
| Closed | -$69.4K | – | 112 |
|
|
2023
Q3 | $69.4K | Sell |
57,373
-612,160
| -91% | -$741K | ﹤0.01% | 118 |
|
|
2023
Q2 | $971K | Hold |
669,533
| – | – | 0.02% | 116 |
|
|
2023
Q1 | $971K | Hold |
669,533
| – | – | 0.02% | 112 |
|
|
2022
Q4 | $1.16M | Sell |
669,533
-101,177
| -13% | -$175K | 0.03% | 110 |
|
|
2022
Q3 | $1.54M | Hold |
770,710
| – | – | 0.04% | 115 |
|
|
2022
Q2 | $571K | Sell |
770,710
-220,203
| -22% | -$163K | 0.02% | 129 |
|
|
2022
Q1 | $8.62M | Buy |
990,913
+45,600
| +5% | +$397K | 0.22% | 87 |
|
|
2021
Q4 | $15.1M | Buy |
945,313
+3,770
| +0.4% | +$60.4K | 0.35% | 75 |
|
|
2021
Q3 | $17.3M | Sell |
941,543
-24,385
| -3% | -$449K | 0.36% | 79 |
|
|
2021
Q2 | $13.5M | Hold |
965,928
| – | – | 0.27% | 99 |
|
|
2021
Q1 | $14.2M | Sell |
965,928
-269,072
| -22% | -$3.96M | 0.31% | 89 |
|
|
2020
Q4 | $23.9M | Sell |
1,235,000
-1,256
| -0.1% | -$24.4K | 0.51% | 69 |
|
|
2020
Q3 | $13.8M | Buy |
1,236,256
+621,079
| +101% | +$6.93M | 0.35% | 84 |
|
|
2020
Q2 | $8.32M | Buy |
615,177
+10,177
| +2% | +$138K | 0.23% | 111 |
|
|
2020
Q1 | $4.89M | Buy |
605,000
+80,000
| +15% | +$646K | 0.2% | 99 |
|
|
2019
Q4 | $5.05M | Hold |
525,000
| – | – | 0.16% | 108 |
|
|
2019
Q3 | $5.57M | Hold |
525,000
| – | – | 0.22% | 98 |
|
|
2019
Q2 | $6.04M | Hold |
525,000
| – | – | 0.22% | 92 |
|
|
2019
Q1 | $6.73M | Hold |
525,000
| – | – | 0.26% | 96 |
|
|
2018
Q4 | $3.23M | Hold |
525,000
| – | – | 0.15% | 114 |
|
|
2018
Q3 | $5.52M | Hold |
525,000
| – | – | 0.2% | 113 |
|
|
2018
Q2 | $7.7M | Hold |
525,000
| – | – | 0.3% | 98 |
|
|
2018
Q1 | $7.48M | Hold |
525,000
| – | – | 0.32% | 95 |
|
|
2017
Q4 | $6.17M | Buy |
+525,000
| New | +$6.17M | 0.28% | 99 |
|